Drugmakers turn to AI to speed trials, regulatory submissions Artificial intelligence has yet to deliver on the most challenging aspect of drug development -- finding new molecules that lead to major medical advances -- but it is already streamlining less glamor...

#Drugmakers turn to #AI to speed trials, regulatory submissions | @Reuters

www.reuters.com/legal/litiga...

#MedSky #AImedicine #AI #HealthAI #AIinHealthcare #MedTech

Original post on newsie.social

#Drugmakers plan to raise #US #prices on at least 350 branded #medications including vaccines against #COVID, #RSV and #shingles and blockbuster cancer treatment #Ibrance, even as the T#rump administration pressures them for cuts, according to data provided exclusively by healthcare research […]

Smoke and mirrors that screw the people… #Drugmakers plan to raise #prices on at least 350 meds, including COVID #vaccines and #cancer treatments, despite efforts by President #Trump to lower them. U.S. patients currently pay more for #prescription #drugs than in other developed nations.

Fake News Trump Lies Again

#Drugmakers plan to RAISE
U.S. PRICES on at least 350 branded medications including vaccines against COVID, RSV and shingles and blockbuster CANCER treatment
#FakeDealsTrump
#POTUS47 LIES AGAIN
#PEDO #TrumpCoverUp

Exclusive: Drugmakers raise US prices on 350 medicines despite pressure from Trump Drugmakers plan to raise U.S. prices on at least 350 branded medications including vaccines against COVID, RSV and shingles and blockbuster cancer treatment Ibrance, even as the Trump administration p...

#Medications #Pharma #BigPharma #Pharmaceuticals #CostOfMedicine #Drugmakers #USHealthcare #DrugPrices

Reuters:

www.reuters.com/business/hea...

From the news community on Reddit: Exclusive: Drugmakers raise US prices on 350 medicines despite pressure from Trump Explore this post and more from the news community

“Exclusive: #Drugmakers raise US prices on 350 medicines despite (supposed) pressure from 47”

www.reddit.com/r/news/s/pzT...

Exclusive: Drugmakers raise US prices on 350 medicines despite pressure from Trump Drugmakers plan to raise U.S. prices on at least 350 branded medications including vaccines against COVID, RSV and shingles and blockbuster cancer treatment Ibrance, even as the Trump administration p...

🤡 As usual, Trump failed.

➡️ Exclusive: #Drugmakers plan to #raise #prices on at least 350 branded #medications including #vaccines against #COVID, #RSV and #shingles and blockbuster cancer treatment #Ibrance, even as the Trump administration pressures them for cuts.

Original post on masto.ai

Exclusive: #Drugmakers raise #US #prices on 350 medicines despite pressure from #Trump

Drugmakers plan to raise US prices on at least 350 branded #medications including #vaccines against #COVID, #RSV & #shingles & blockbuster #cancer treatment Ibrance, even as the Trump admin pressures them for […]

Virginia sues PBMs, manufacturers over alleged insulin pricing scheme The lawsuit alleged a years-long insulin pricing scheme that artificially inflated the price of lifesaving diabetes medications and deceived consumers about those inflated prices.

The complaint alleges that manufacturers required PBMs to inflate drug prices to gain formulary access and then paid an undisclosed amount of the cost back to the #PBM. #RxCosts #Insulin #Drugmakers #Litigation #Virginia

Science For Sale: How Drugmakers Captured The FDA The pharmaceutical industry spent decades manipulating the country’s top drug regulator into rubber-stamping its products. The Trump administration is making matters worse.

#FDA
#Corruption
#Drugmakers

www.levernews.com/science-for-...

#trends today for 'jeffrey epstein' 'join forces' & 'drug makers'

Click/Tap below:

www.newsmason.com?query=%22jef...

www.newsmason.com?query=%22joi...

www.newsmason.com?query=%22dru...

#jeffreyepstein #joinforces #drugmakers

Original post on masto.ai

How #PrivateEquity Oversees the #Ethics of #DrugResearch

Many #DrugTrials are vetted by companies with ties to the #drugmakers, raising concerns about #ConflictsOfInterest & #patient #safety.

#law #PublicHealth […]

Nearly 700 drugs see price hikes under Trump: Report Prices for 688 prescription medications have increased since President Donald Trump took office, according to a Sept. 29 report from Sen. Bernie Sanders…

The report marks 60 days since President Trump sent letters to #drugmakers requesting price reductions. In that time [alone], 87 drugs have gone up in price, with a median increase of 8%. Companies raised prices after receiving the administration’s request. #RxCosts

Sanders Report Shows Prices for 688 Prescription Drugs Rose Under Trump | Common Dreams As President Donald Trump's deadline for drugmakers to commit to cutting prices expired, Sen. Bernie Sanders released a report showing that the cost of hundreds of prescriptions has risen since his re...

As President #Trump’s deadline for large #drugmakers to make “binding commitments” to cut prices expired on Monday, Sen. #BernieSanders released a report showing that the cost of hundreds of #prescriptions has risen in the United States since the Republican returned to office in January.

Original post on newsie.social

#Texas lawmakers approved bill allowing nearly anyone to #sue providers, manufacturers and even delivery companies like #FedEx for #shipping #abortion pills into state. Gov. #GregAbbott will sign w backers calling it a #blueprint for other states to copy. This deputizes citizens as #bounty […]

The murkiness of drug companies’ price transparency reports Why pharma companies' "price transparency" reports paint a murky picture of how much Americans spend on prescription drugs.

Great article about how drugmakers use "transparency reports" to tell a wildly different story about the cost of prescription drugs than what most Americans actually experience.

www.statnews.com/2025/08/04/d...

#drugmakers #prescriptiondrugcost #transparency #healthpolicysky #OCAP

US pharma bets big on China to snap up potential blockbuster drugs U.S. drugmakers are licensing molecules from China for potential new medicines at an accelerating pace, according to new data, betting they can turn upfront payments of as little as $80 million into multibillion-dollar treatments.

🚨Through June, U.S. #drugmakers signed 14 deals potentially worth $18.3 billion to #license #drugs from China-based companies. That compares with just two such deals in the year-earlier period, according to data from #GlobalData provided exclusively to #Reuters.

UK follows through on doubling of statutory scheme rate UK pharma firms have reacted angrily to the news that the government has doubled the statutory scheme rebate on the sales of newer drugs to the NHS.

The #UK #pharma industry has reacted angrily to the news that the #government has doubled the rate that #drugmakers must repay on the sales of newer products to the #NHS under the so-called #statutoryscheme.

Original post on benzinga.com

Jim Cramer Says 'Price Controls Are Not Like Tariffs' — Urges Drugmakers To Challenge T...

www.benzinga.com/markets/equities/25/05/4...

#benzinga […]

[Original post on benzinga.com]

Britiain’s GSK says ’well positioned’ to absorb possible pharma tariff hit (Reuters) - British drugmaker GSK said it was "well positioned" to respond to any potential impact from sector-specific tariffs if they were implemented and it had identified options within its supply chain and productivity initiatives to mitigate any hit. U.S. President Donald Trump this month reiterated plans for a "major" tariff on pharmaceutical imports, but he has not said when and by how much he plans to raise levies on pharmaceutical imports which could threaten an interwoven global supply chain and raise U.S. drug costs by $51 billion annually. Still, GSK reaffirmed its 2025 forecasts on Wednesday after higher first-quarter turnover of 7.52 billion pounds ($10.07 billion) and core profit of 44.9 pence per share surpassed analysts’ expectations. It was not immediately clear whether the drugmaker’s outlook had factored in the impact from tariffs and the company did not give further details on the options identified. ($1 = 0.7468 pounds)

Click Subscribe #GSK #Pharma #Tariffs #Drugmakers #SupplyChain

Original post on masto.ai

This would be a surprisingly good thing if it happened. Somehow I doubt #BigPharma & #Republicans will allow it.

#Drugmakers have been warned that the #Trump Administration is considering linking US #medicine #prices to lower amounts paid by other developed countries, acc/to 2 company sources […]

Trump signs healthcare executive order that includes a win for pharma companies U.S. President Donald Trump directed his health department to work with Congress on revamping a law that allows Medicare to negotiate prescription drug prices, seeking to introduce a change the pharma...

#PharmaNews | Trump’s new #healthcare order could be a win for Big Pharma. He wants #Medicare to delay price talks for pill-based drugs—giving them 13 years, like biotech meds. That’s 4 extra years of profits for #drugmakers. But he needs Congress to make it official. His plan also pushes for...

European pharma companies warn Trump’s tariffs could expedite shift to US, sources say Blog Mobile Portfolio Widgets About Us Advertise Help & Support Authors Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

Click Subscribe. #pharmaceuticals #healthcare #EU #USTariffs #drugmakers

Trump Warns Drugmakers of Tariffs, Urges US Manufacturing Shift Amid Pricing Tensions - #WorldEye

youtu.be/NfxVzRNEOPQ

#Trump #Drugmakers #Tariffs #USManufacturing #DrugPricing #PharmaIndustry #PrescriptionDrugs

Drugmakers hiked prices for hundreds of drugs in early January — NPR January is a big time for drugmakers to hike prices. This year saw higher prices for 575 medications so far, including Ozempic, drugs for HIV, cancer and many others.

Funny how Merican’ corporation can raise product prices, #CEO pay & shareholder dividends & fuck over their #employee with chump change #wages & WE TAKE IT ALL AS GOSPEL? Err’body cept’ Luigi

apple.news/APEcumQDxRY6...

#Drugmakers hiked prices for hundreds of drugs in early January - NPR

#drugmakers plan to raise US prices (median: +4.5%) on at least 250 branded medications including #Pfizer’s COVID19 treatment Paxlovid, #BristolMyersSquibb's cancer cell therapies and vaccines from France's Sanofi at the start of 2025, chart @reuters.com
www.reuters.com/business/hea...

image for call to action to the drug and pharma industries for making industrial films to generate business leads

#Industrial #filmmaking for #pharma #industries and #drugmakers involves extensive use of 3D programs like #3DsMax, #Maya and #Blender. Write us to info@creativesnext.com for more information and a quote.
#industrialfilms #corporatefilms #medicalanimations #medicalillustrations #medicines #3dscenes

U.S. Senate Passes FDA Modernization Act 3.0, Sends Urgent Measure to House for Final Action Today, the U.S. Senate passed the FDA Modernization Act 3.0, S. 5046, to compel the U.S. Food and Drug Administration to get on with the task of winding down the era of animal testing in drug developm...

Is this the end of #AnimalTesting to develop new drugs in the #USA 🇺🇸 ?
Isn't it time for the #FDA to follow the #FDAModernizationActs?

#USpoli #AnimalResearch #AnimalCruelty #AnimalWelfare #Science #DrugMakers #HumaneScience #AnimalRights #LabAnimals

animalwellnessaction.org/us-senate-pa...

What Drugmakers Did Not Tell Volunteers in Alzheimer’s Trials (Gift Article) Genetic tests showed that certain patients were predisposed to brain injuries if they took the drugs. That information remained secret.

If this is what drugmakers do to humans, one can only imagine the suffering of animals to produce these products. ⬇️

What #Drugmakers Did Not Tell Volunteers in #Alzheimer’s Trials

#Eisai #EliLilly #DrugTesting #AnimalTesting #AnimalWelfare #AnimalRights #Health

www.nytimes.com/2024/10/23/h...